Sars-Cov-2 Antibody Test

SARS-CoV-2 IgG/IgM Rapid Test Kit

abx294171-100g 100 µg
EUR 1525

Human IgG antibody Laboratories manufactures the sars-cov-2 antibody test reagents distributed by Genprice. The Sars-Cov-2 Antibody Test reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact SARS Test. Other Sars-Cov-2 products are available in stock. Specificity: Sars-Cov-2 Category: Antibody Group: Test

SARS-CoV-2 Neutralization Antibody Rapid Test Kit

1 ml
EUR 22500

SARS-CoV-2 Neutralization Antibody Rapid Test Kit

200 µl
EUR 6600

SARS-CoV-2 Antigen Rapid Test

25 Tests
EUR 8.75

Mikrogen Diagnostik recomLine SARS-CoV-2 IgG Lateral Strip Test Kit

20 Tests
EUR 880

CoV-2 IgG S1

50µg
EUR 900
Description: Recombinant Anti Human SARS CoV-2 IgG Spike S1

CoV-2 IgG ELISA

96 tests
EUR 758
Description: IgG Screening ELISA

CoV-2 IgG+ ELISA

24 x 4 tests
EUR 948
Description: IgG+ Confirmatory ELISA

Test information

SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody

abx137719-100tests 100 tests
EUR 1237.5

SARS CoV-2 IgG Spike S1 (CoV-2 IgG S1) Antibody

abx137720-100tests 100 tests
EUR 1237.5

SARS CoV-2 IgM Spike S1 (CoV-2 IgM S1) Antibody

abx137721-100tests 100 tests
EUR 225

SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] 100 ul

BSV-COV-AB-02 100 ul
EUR 602
Description: SARS-CoV/ SARS-CoV-2 (COVID-19) spike antibody [1A9] (Spike (S2), Monoclonal)

OAEF00177-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00177-1MG 1mg
EUR 471

OAEF00179-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00179-1MG 1mg
EUR 471

OAEF00193-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00193-1MG 1mg
EUR 471

OAEF00194-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00194-1MG 1mg
EUR 471

OAEF00195-1MG - Coronavirus (COVID-19) (SARS-CoV-2) (SARS-CoV NP) Antibody

OAEF00195-1MG 1mg
EUR 471

SARS-CoV-2 and Influenza A+B Antigen Combo Rapid Test

ISIN-525H 25 Tests
EUR 18.75

SARS Antibody (CoV) (Spike)

GWB-31A5B4 0.1 mg Ask for price

SARS Antibody (CoV Spike)

GWB-7E7002 0.1 mg Ask for price

SARS CoV/SARS CoV 2 Spike Human mAb

E2S209908 100ul
EUR 595
Description: Biotin-Conjugated, FITC-Conjugated , AF350 Conjugated , AF405M-Conjugated ,AF488-Conjugated, AF514-Conjugated ,AF532-Conjugated, AF555-Conjugated ,AF568-Conjugated , HRP-Conjugated, AF405S-Conjugated, AF405L-Conjugated , AF546-Conjugated, AF594-Conjugated , AF610-Conjugated, AF635-Conjugated , AF647-Conjugated , AF680-Conjugated , AF700-Conjugated , AF750-Conjugated , AF790-Conjugated , APC-Conjugated , PE-Conjugated , Cy3-Conjugated , Cy5-Conjugated , Cy5.5-Conjugated , Cy7-Conjugated Antibody

SARS-CoV-2 (COVID-19) NSP7 Antibody

9155-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.

SARS-CoV-2 (COVID-19) NSP7 Antibody

9155-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP7 plays a role in viral RNA synthesis (3,4,5). It forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers.

SARS-CoV-2 (COVID-19) NSP8 Antibody

9159-002mg 0.02 mg
EUR 229.7
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6).

SARS-CoV-2 (COVID-19) NSP8 Antibody

9159-01mg 0.1 mg
EUR 594.26
Description: Coronavirus disease 2019 (COVID-19), formerly known as 2019-nCoV acute respiratory disease, is an infectious disease caused by SARS-CoV-2, a virus closely related to the SARS virus (1). The disease is the cause of the 2019–20 coronavirus outbreak (2). The structure of 2019-nCoV consists of the following: a spike protein (S), hemagglutinin-esterease dimer (HE), a membrane glycoprotein (M), an envelope protein (E) a nucleoclapid protein (N) and RNA. NSP8 plays a role in viral RNA synthesis (3,4,5). Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, it may synthesize substantially longer products than oligonucleotide primers (6).